Last 1,053 GBp
Change Today +7.00 / 0.67%
Volume 2.6M
RR/ On Other Exchanges
Symbol
Exchange
London
OTC US
OTC US
Frankfurt
Frankfurt
As of 11:35 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Russell Cummings

Chief Executive Officer, Executive Director, and Member of Investment Committee, Imperial Innovations Group plc
AgeTotal Calculated CompensationThis person is connected to 53 board members in 5 different organizations across 8 different industries.

See Board Relationships
50236,083 GBP
As of Fiscal Year 2013

Background*

Mr. Russell Cummings, also known as Russ, has been the Chief Executive Officer since July 17, 2013 and Executive Director since September 18, 2006 at Imperial Innovations Group plc. Mr. Cummings manages the investment portfolio and decision-making process. He has a strong track record as an investor in early stage and high growth companies spanning both the healthcare and technology sectors. Mr. Cummings served as the Chief Investment Officer at Imperial Innovations ...

Read Full Background

Corporate Headquarters*

65 Buckingham Gate
London, Greater London SW1E 6AT

United Kingdom

Phone: 44 20 7222 9020
Fax: 44 20 7227 9170

Board Members Memberships*

Director
Former Director
Director
Former Director
Director
Director
Director
2006-Present
Chief Executive Officer, Executive Director, and Member of Investment Committee

Education*

BS
Imperial College

Other Affiliations*

Annual Compensation*

Salary210,000 GBP
Total Annual Compensation210,000 GBP

Stock Options*

All Other Compensation26,083 GBP
Unexercisable Options171,428
Total Number of Options171,428

Total Compensation*

Total Annual Cash Compensation236,083 GBP
Total Short Term Compensation210,000 GBP
Other Long Term Compensation26,083 GBP
Total Calculated Compensation236,083 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RR/:LN 1,053.00 GBp +7.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James T. LaFrance Chairman, Chief Executive Officer and President
Vermillion, Inc.
--
Peter D. Meldrum Ph.D.Chief Executive Officer, President and Director
Myriad Genetics Inc.
$956.9K
Kevin Kowbell Chairman and Interim Chief Executive Officer
Health Discovery Corporation
--
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
C$247.9K
Jan Groen Ph.D.Chief Executive Officer and Executive Director
MDxHealth SA
€470.7K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROLLS-ROYCE HOLDINGS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.